I
T is a generally held clinical impression that hypertension occurs more frequently among diabetic patients than in the general population. Attempts to confirm this association by epidemiological techniques raise many methodological problems involving the study of the interaction between two common but arbitrarily defined conditions. Hypertension has been implicated in the pathogenesis of diabetic macrovascular and microvascular disease, 1 and an important question still to be answered is whether or not treating hypertension will reduce the burden of mortality and morbidity in diabetic patients.
Frequency of Hypertension among Diabetic
Patients Many studies have attempted to demonstrate an association between hypertension and diabetes mellitus, but methodological problems often make their interpretation difficult. 1 ' 2 Most earlier studies were of the case-control type in which arterial blood pressure (BP) in diabetic patients was compared with those in nondiabetic controls. Often the characteristics of the diabetic groups were poorly defined with regard to factors that might influence BP, such as age, degree of obesity, presence of renal disease, and type of diabetes and treatment. Similar criticisms can also be applied to the nondiabetic control groups, which have often com-prised other hospital patients, hospital visitors, or medical personnel.
Several factors are known to influence the level of arterial BP in an individual, including time of day, room temperature, period of rest preceding BP measurement, prior cigarette smoking, posture, stress, and medication. 3 There is also the problem of observer variation, which is minimized by adequate training of observers and the use of blind or random-zero sphygmomanometers. Arm girth should also be taken into account and the appropriate cuff size used. These methodological considerations make it clear that in any BP study, measurements in cases and controls should be made by the same observers under standardized conditions using adequate quality control.
3 Several large, often quoted studies in diabetics have not fulfilled these conditions, however, making their results difficult to interpret. In the study of Freedman et al. 4 of 1100 diabetic patients, control data were obtained from the study of Hamilton et al. 5 of BP in a random outpatient population, and cases and controls were clearly not studied under the same conditions. In both sexes, the prevalence of hypertension (defined as diastolic BP >100 mm Hg) was not significantly increased in diabetic patients except for the age range 70 to 79 years. Severe hypertension (diastolic BP > 125 mm Hg) was rare and malignant hypertension absent in their diabetic group. Keen et al. 6 in their clinical study of 735 diabetics also used the control data of Hamilton et al. 5 and found no systematic BP differences between diabetics and controls, although age-and sex-adjusted diastolic BP scores were increased, particularly for diabetics below age 40 years. Neither of these studies (or previous ones) classified patients according to type of diabetes. Two studies, however, were carried out in patients with juvenileonset insulin-dependent diabetes (IDD). Moss 7 compared systolic BPs in 123 diabetic children aged 8 to 20 years with those in 889 nondiabetics in the same age range and found significantly increased levels in diabetics over 13 years. Another study of 900 patients with IDD attending the Joslin Clinic in 1964 used control data from the Framingham Study and the U.S. Survey of Hypertension. 8 A higher prevalence of hypertension, defined as systolic BP at least 160 mm Hg or diastolic BP at least 95 mm Hg, was present in patients with IDD than in controls, particularly in female subjects. In neither of these two studies was there a consistent relationship between hypertension and duration of diabetes.
The importance of the source of the population used to study the possible association between these diseases has been stressed by Gerber et al., 9 who noted that hypertension and diabetes coexisted more frequently in a hospital clinic population (6.0%) than a work-site population (1.9%). They cited these findings as an example of Berkson's paradox, which states that if patients with different diseases are hospitalized at different rates, substantial distortions may occur when conclusions about the concurrence of the diseases are drawn from hospital populations.
10 -" Studying BP in diabetic patients identified by population surveys may overcome some of the methodological difficulties of clinic-based studies, particularly those of selectivity of patients and comparability of controls. Pell and D'Alonzo 12 compared the BPs of 662 diabetic employees of the DuPont Company with an equal number of nondiabetic employees, matched for age, sex and employment status. They found that the prevalence of hypertension (systolic BP 150 mm Hg or above; diastolic BP 94 mm Hg or above) was 54% higher in the diabetic persons and it was also increased in each category of body weight. Hypertension was more common in diabetic patients even prior to the diagnosis of diabetes.
Garcia et al. 13 reported from the Framingham Study that mean systolic BPs were increased in diabetics, more so in female than male subjects, but adjustment for degree of obesity was not made. In the Bedford Survey, 14 systolic BPs were significantly higher in persons of both sexes with newly detected and borderline diabetes than in normoglycemic controls, even after adjustment for age and degree of obesity. Similar results were obtained in the Whitehall Study of London male civil servants, 14 but mean BPs were not elevated in those with previously diagnosed diabetes. In a population survey in Maryland (USA), diabetic patients had higher systolic BPs than controls, but adjustment for obesity was not made. 13 Mean BPs of older adults aged 50 to 79 years in California adjusted for age and obesity, were lowest for nondiabetics, intermediate for those with newly detected disease, and highest for persons previously known to have diabetes. 16 The magnitude of the differences was small, however, and was statistically significant only for female subjects.
In summary, there does seem to be some evidence for increased frequency of systolic hypertension in diabetes, particularly for the older age groups, but the relationship of diabetes to diastolic hypertension is less convincing. 1 The finding of raised levels of systolic BP in young persons with IDD 7> 8 may have important prognostic implications and needs to be confirmed by carefully designed studies that take into account the methodological problems discussed.
Possible Mechanisms for the Relationship between Hypertension and Diabetes
In many studies in nondiabetic populations, statistically significant correlations were found between BP and various measurements of glycemia.
14 -l7 This relationship seemed to be independent of age, degree of obesity, and heart rate, and was stronger in individuals with higher heart rates.
1418 " 20 Attempts have been made to explain this association in terms of the influence of sympathetic pathways, neutral or humoral, on both BP and blood glucose regulation.
1420 This is unlikely to be a complete explanation, however, since an association between these two variables remains after adjustment for heart rate, assumed to be an index of sympathetic activity. Other possible pathogenic mechanisms for the association between hypertension and diabetes were reviewed by Drury.
1 They include abnormalities in catecholamines, insulin and renal sodium metabolism, and the renin-angiotensin system. Such hypotheses are difficult to confirm by epidemiological studies because of the methodological problems of measuring the biochemical variables in large numbers of subjects. 21 Both diabetes and hypertension can rarely occur secondarily to endocrine diseases such as thyrotoxicosis, pheochromocytoma, Cushing's syndrome, acromegaly, and primary hyperaldosteronism. The frequency of renal artery stenosis does not seem to be increased in diabetes. 
Hypertension and Mortality in Patients
with Diabetes Cohort and insurance studies 22 '" indicated that mortality among persons with diabetes increases with elevation of both systolic and diastolic BP, but the exact role of hypertension in the etiology of diabetic macrovascular and microvascular disease remains unclear. 1 -24 In developed countries, both persons with diabetes and subjects with glucose intolerance have an increased risk of death from coronary heart disease (CHD) and stroke. 24 -23 For these hyperglycemic groups, the relative importance of cardiovascular risk factors established for normoglycemic populations remains uncertain.
In their follow-up study of 371 diabetics and 742 controls, Dupree and Meyer 15 found that, compared to normotensive controls, mortality rates were 4 times greater for diabetics with systolic BP 160 mm Hg or above against an increase of 1.5 times for BPs below that level. In a 10-year follow-up of persons with borderline diabetes from the Bedford Survey, systolic BP was a significant predictor of CHD mortality even EPIDEMIOLOGY OF DIABETES AND HYPERTENSION/Fu//er II-5 allowing for other related factors such as age and obesity. 26 The relationship of risk factors, including BP, to the frequency of cardiovascular disease over a 20-year period (the Framingham Study) did not differ between diabetics and nondiabetics. 27 This was not confirmed by the Whitehall Study, 28 in which systolic and diastolic pressures had a more consistent relationship to CHD mortality in those with glucose intolerance and diabetes than did cholesterol, obesity, and cigarette smoking. 29 When subjects were arbitrarily divided into hypertensive and normotensive groups (Table 1) , the relative risks for CHD death were higher in those with glucose intolerance than with normoglycemia. For the diabetic group, the relative risk was higher only when systolic BP was used.
Studies of national mortality statistics 25 and cohort studies 13 showed an increased risk of stroke death associated with diabetes. Stroke mortality rates were also increased in men with glucose intolerance and diabetes in the Whitehall Study, 29 with age and systolic BP being important contributors to the increased risk. For both CHD and stroke mortality, a large proportion of the excess mortality risk was not explainable by measured cardiovascular risk factors.
For those in whom diabetes is diagnosed below the age of 31 years, renal disease is an important contributor to mortality, accounting for 31 % of all deaths, and patients with persistent proteinuria have three to four times the mortality compared to those without proteinuria. 30 Keen et al. 31 noted a significant correlation between arterial BP in diabetics and the urinary excretion rate of microalbumin, which has been shown to be a strong predictor of subsequent clinical renal disease. 32 Other studies have shown that hypertension is often present in young persons with type I diabetes (IDD) with diabetic nephropathy 33 -M and may contribute to the progression of renal disease. Mogensen 35 and Parving et al. 36 suggested that antihypertensive treatment may slow the rate of decline in renal function in patients with diabetic nephropathy.
Geographical Variation in Frequency of Hypertension among Diabetics
Virtually all of the clinic-and population-based studies of hypertension and diabetes discussed above were carried out in Western, developed communities. Further information on the frequency of hypertension in a wide variety of diabetic populations has come from the World Health Organization (WHO) Multinational Study of Vascular Disease in Diabetics. 37 A total of 6695 diabetic men and women, aged 35 to 54 years, from 14 centers participated in this prevalence study. In each center a random sample of diabetic patients was drawn, stratified by age, sex, and duration of diabetes. Standardized examination procedures were carried out, including the measurement of arterial BP. About 34% of the patients were hypertensive (systolic BP above 160 mm Hg, diastolic BP above 95 mm Hg, or receiving treatment for hypertension), the proportion being somewhat greater for women (36.0%) than men (31.8%) ( Table 2 ). The highest frequencies of hypertension occurred in Moscow and Berlin (GDR) for men and Zagreb and Moscow for women, and the lowest were in London for men and Arizona for women. These differences were not related to variations in degree of obesity among the centers.
Treatment of Hypertension in Diabetes
Apart from the few small studies of treatment of hypertension in diabetic nephropathy mentioned, no randomized, controlled trials of antihypertensive treatment have been carried out in diabetic patients. Thus decisions regarding the efficacy of such treatment must be based upon evidence, often controversial, extrapolated from studies in nondiabetic populations. 38 Weight loss would seem to be of benefit in the hypertension associated with obesity and noninsulindependent diabetes. 39 Some national dietary recommendations included sodium restriction, 40 but the problem of compliance with such stringent diets has not been adequately studied in representative groups of diabetics. Nearly all antihypertensive drugs have some disadvantages when used in persons with diabetes, 1 and this may be particularly true for the commonly used thiazide diuretics 41 and beta-adrenergic receptor blockers. 42 Probably as a result of the uncertainty, the numbers of treated diabetic patients varies considerably from center to center, as in the WHO Study (see Table 2 ). The lowest frequencies of treatment occurred in London and Brussels (less than 8%), whereas the highest occurred in Moscow (32% for men and 39% for women). For all centers combined, treatment rates were higher for women (20.8%) than men (15.4%). In the United States, an analysis of the pharmaceutical records of 2773 diabetic patients indicated that nearly one-half were taking diuretics and almost one-quarter were using other antihypertensive drugs. 43 
Conclusion
In spite of the methodological problems of many of the studies reviewed, the balance of evidence points to increased frequency of hypertension in diabetic populations. This increase is mainly in the older age groups and seems to persist after allowance for possible confounding factors such as obesity. Epidemiological evidence is accumulating that hypertension is an important factor in the increased risk of CHD and stroke 37 death in subjects with diabetes and glucose intolerance. It may also be important in the etiology of some forms of diabetic retinopathy and contribute to the worsening of renal function in diabetics. The WHO Multinational Study demonstrated that hypertension is being detected and actively treated in diabetics, but more evidence is required from randomized controlled trials as to the indications for such treatment (particularly for sustained BPs in the mild range), since all antihypertensive agents have disadvantages, some of them serious, when used for diabetic patients.
